These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses. Tomov VT; Osborne LC; Dolfi DV; Sonnenberg GF; Monticelli LA; Mansfield K; Virgin HW; Artis D; Wherry EJ J Virol; 2013 Jun; 87(12):7015-31. PubMed ID: 23596300 [TBL] [Abstract][Full Text] [Related]
26. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. Mumphrey SM; Changotra H; Moore TN; Heimann-Nichols ER; Wobus CE; Reilly MJ; Moghadamfalahi M; Shukla D; Karst SM J Virol; 2007 Apr; 81(7):3251-63. PubMed ID: 17229692 [TBL] [Abstract][Full Text] [Related]
27. The Role of Host Glycobiology and Gut Microbiota in Rotavirus and Norovirus Infection, an Update. Peña-Gil N; Santiso-Bellón C; Gozalbo-Rovira R; Buesa J; Monedero V; Rodríguez-Díaz J Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948268 [TBL] [Abstract][Full Text] [Related]
29. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go? Ramani S; Estes MK; Atmar RL PLoS Pathog; 2016 Apr; 12(4):e1005334. PubMed ID: 27115358 [No Abstract] [Full Text] [Related]
30. Interactions between noroviruses, the host, and the microbiota. Walker FC; Baldridge MT Curr Opin Virol; 2019 Aug; 37():1-9. PubMed ID: 31096124 [TBL] [Abstract][Full Text] [Related]
31. Caspase-mediated cleavage of murine norovirus NS1/2 potentiates apoptosis and is required for persistent infection of intestinal epithelial cells. Robinson BA; Van Winkle JA; McCune BT; Peters AM; Nice TJ PLoS Pathog; 2019 Jul; 15(7):e1007940. PubMed ID: 31329638 [TBL] [Abstract][Full Text] [Related]
32. Severe viral gastroenteritis in children after suboptimal rotavirus immunization in Taiwan. Chen SY; Tsai CN; Chen CL; Chao HC; Lee YS; Lai MW; Chen CC; Huang WL; Chiu CH Pediatr Infect Dis J; 2013 Dec; 32(12):1335-9. PubMed ID: 23881091 [TBL] [Abstract][Full Text] [Related]
33. New insights into the global burden of noroviruses and opportunities for prevention. Hall AJ; Glass RI; Parashar UD Expert Rev Vaccines; 2016 Aug; 15(8):949-51. PubMed ID: 27142965 [No Abstract] [Full Text] [Related]
34. Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children. Payne DC; Parashar UD; Lopman BA Curr Opin Pediatr; 2015 Feb; 27(1):105-9. PubMed ID: 25490691 [TBL] [Abstract][Full Text] [Related]
35. Nlrp6 regulates intestinal antiviral innate immunity. Wang P; Zhu S; Yang L; Cui S; Pan W; Jackson R; Zheng Y; Rongvaux A; Sun Q; Yang G; Gao S; Lin R; You F; Flavell R; Fikrig E Science; 2015 Nov; 350(6262):826-30. PubMed ID: 26494172 [TBL] [Abstract][Full Text] [Related]
36. Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions. Pearson JA; Tai N; Ekanayake-Alper DK; Peng J; Hu Y; Hager K; Compton S; Wong FS; Smith PC; Wen L Front Immunol; 2019; 10():2654. PubMed ID: 31798584 [TBL] [Abstract][Full Text] [Related]